Get started
Author

Alessia Bono

Observed name: Bono, Alessia
ORCID: 0000-0002-9283-4920
Observed ORCID: 0000-0002-9283-4920
OpenAlex ID: A5071445538
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
2022 · Gabriele La Monica, Alessia Bono, et al. · Journal of Medicinal Chemistry · 173
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets
2021 · Antonino Lauria, Gabriele La Monica, et al. · European Journal of Medicinal Chemistry · 103
Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry
2024 · Gabriele La Monica, Alessia Bono, et al. · Bioorganic & Medicinal Chemistry · 21
PDF
In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents
2023 · Alessia Bono, Gabriele La Monica, et al. · International Journal of Molecular Sciences · 15
PDF
Novel Antibacterial 4-Piperazinylquinoline Hybrid Derivatives Against Staphylococcus aureus: Design, Synthesis, and In Vitro and In Silico Insights
2024 · Gabriele La Monica, Annamaria Gallo, et al. · Molecules · 14
PDF
Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors
2021 · Gabriele La Monica, Antonino Lauria, et al. · International Journal of Molecular Sciences · 12
PDF
Spatiotemporal control of prodrug activation through external stimuli for effective and safe on-site release in solid tumors: From current advances to future perspectives
2026 · Gabriele La Monica, Alessia Bono, et al. · Drug Discovery Today · 11
Design and Synthesis of Novel Thieno[3,2-c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells
2023 · Gabriele La Monica, Giuseppe Pizzolanti, et al. · ACS Omega · 11
PDF
Synthesis of new antiproliferative 1,3,4-substituted-pyrrolo[3,2-c]quinoline derivatives, biological and in silico insights
2023 · Francesco Mingoia, Caterina Di Sano, et al. · European Journal of Medicinal Chemistry · 11
Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel
2022 · Annamaria Martorana, Gabriele La Monica, et al. · International Journal of Molecular Sciences · 11
PDF
Scaffold-Hopping Strategies in Aurone Optimization: A Comprehensive Review of Synthetic Procedures and Biological Activities of Nitrogen and Sulfur Analogues
2024 · Gabriele La Monica, Federica Alamia, et al. · Molecules · 9
PDF
In Silico Design of New Dual Inhibitors of SARS-CoV-2 MPRO through Ligand- and Structure-Based Methods
2023 · Alessia Bono, Antonino Lauria, et al. · International Journal of Molecular Sciences · 9
PDF
A novel in silico approach for identifying multi-target JAK/STAT inhibitors as anticancer agents
2024 · Alessia Bono, Gabriele La Monica, et al. · Journal of Molecular Graphics and Modelling · 6
PDF
Design, Synthesis, and In Silico Insights of new 4‐Piperazinylquinolines as Antiproliferative Agents against NCI Renal Cancer Cell Lines
2025 · Gabriele La Monica, Alessia Bono, et al. · ChemistryOpen · 4
Antiproliferative Properties and G-Quadruplex-Binding of Symmetrical Naphtho[1,2-b:8,7-b’]dithiophene Derivatives
2021 · Antonino Lauria, Gabriele La Monica, et al. · Molecules · 3
PDF
B.R.E.A.S.T. Breast canceR Enhanced AI-Supported Therapy: A New Interpretable Proteomics-Driven Machine Learning Framework for Therapy Response Prediction in Breast Cancer
2026 · Alessia Bono, Gabriele La Monica, et al. · International Journal of Molecular Sciences · 2
Imidazole-Functionalized Thieno[3,2- c ]quinolines as Promising Antiproliferative Agents: Design, Synthesis, NCI-60 Screening, and Computational Analysis
2026 · Gabriele La Monica, Alessia Bono, et al. · ACS Omega · 2
PDF
Tuning Scaffold Properties of New 1,4-Substituted Pyrrolo[3,2-c]quinoline Derivatives Endowed with Anticancer Potential, New Biological and In Silico Insights
2025 · Francesco Mingoia, Caterina Di Sano, et al. · Biomolecules · 2
PDF
Combinatorial chemistry-driven In silico design and computational evaluation of covalent peptidomimetic SARS-CoV-2 main protease inhibitors via structure-based virtual screening and multivariate analysis
2025 · Alessia Bono, Gabriele La Monica, et al. · Journal of Molecular Graphics and Modelling · 2
In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach
2024 · Gabriele La Monica, Federica Alamia, et al. · Molecules · 2
PDF
Correction to “Design and Synthesis of Novel Thieno[3,2-c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells”
2023 · Gabriele La Monica, Giuseppe Pizzolanti, et al. · ACS Omega · 1
PDF
6-Chloropyridinyl Benzoate Fragments as Selective Anti-Melanoma Scaffolds Triggering ROS-Mediated Mitochondrial Apoptosis
2026 · Gabriele La Monica, Ignazio Restivo, et al. · ACS Omega
PDF
Imidazole-Functionalized Thieno[3,2-c]Quinoline Hybrids in Aggressive Medullary Thyroid Cancer Cell Models: Biological Evaluation and in Silico Insights
2026 · Gabriele La Monica, Alessia Bono, et al. · Pharmaceuticals
B.R.E.A.S.T.TNBC: A Subtype-Specific Interpretable Machine Learning Framework for Proteomic Prediction of Therapy-Related Outcomes in Triple-Negative Breast Cancer
2026 · Alessia Bono, Gabriele La Monica, et al. · SSRN Electronic Journal
A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents
2025 · Alessia Bono, Gabriele La Monica, et al. · Pharmaceuticals
Works count: 31
Citation count: 424
H-index: 10
I10-index: 10
Year
Topic
Type